CareLit · DOI-Nachweis · Zeitschrift für Orthopädie und Unfallchirurgie
Inhibitor development and management in three non-severe haemophilia A patients with T295A variant
DOI 10.5482/hamo-14-02-0013
Bibliografische Angaben
Nachweis in CareLit
Autor:innenHorneff, S.; Marquardt, N.; Klein, C.; Albert, T.; Zeitler, H.; Oldenburg, J.; Ivaskevicius, V.; Goldmann, G.
ZeitschriftZeitschrift für Orthopädie und Unfallchirurgie
AusgabeS 01/2014
Jahrgang / SeitenJg. 34 · S. S9-S12
Kernaussage aus der Literatur
Abstract-Vorschau
SummaryMissense mutations are the most common F8 gene defects among the patients with nonsevere haemophilia A. This type of mutation is typically associated with low (5%) inhibitor risk. In the present retrospective study we analysed the clinical data of 16 haemophiliacs with the T295A missense mutation treated at Bonn Haemophilia Centre. In total, three patients developed inhibitors: two patients experienced low-ti…
Zitieren
Zitierempfehlung
Horneff, S.; Marquardt, N.; Klein, C.; Albert, T.; Zeitler, H.; Oldenburg, J.; Ivaskevicius, V.; Goldmann, G (2014) Inhibitor development and management in three non-severe haemophilia A patients with T295A variant. Zeitschrift für Orthopädie und Unfallchirurgie, 34 (S 01), S9-S12. https://doi.org/10.5482/hamo-14-02-0013
Mit CareLit weiterarbeiten